- Featured News /
Latest news and interviews for media and investors
- Pulse Update /
- Statement /
- Statement /
Novartis and BeiGene, Ltd. have mutually agreed to terminate the collaboration and license agreement for tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody.
- Featured News /
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
- Featured News /
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
- Statement /
Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.
- Featured News /
Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.
- Statement /
- Statement /
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 20
- › Next page